These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11585217)

  • 1. Theoretical estimation of absorbed dose to organs in radioimmunotherapy using radionuclides with multiple unstable daughters.
    Hamacher KA; Sgouros G
    Med Phys; 2001 Sep; 28(9):1857-74. PubMed ID: 11585217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular dose conversion factors for alpha-particle--emitting radionuclides of interest in radionuclide therapy.
    Hamacher KA; Den RB; Den EI; Sgouros G
    J Nucl Med; 2001 Aug; 42(8):1216-21. PubMed ID: 11483682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A schema for estimating absorbed dose to organs following the administration of radionuclides with multiple unstable daughters: a matrix approach.
    Hamacher KA; Sgouros G
    Med Phys; 1999 Dec; 26(12):2526-8. PubMed ID: 10619234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo dosimetry of a realistic multicellular model of follicular lymphoma in a context of radioimmunotherapy.
    Bordes J; Incerti S; Mora-Ramirez E; Tranel J; Rossi C; Bezombes C; Bordenave J; Bardiès M; Brown R; Bordage MC
    Med Phys; 2020 Oct; 47(10):5222-5234. PubMed ID: 32623743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide.
    Frampas E; Maurel C; Remaud-Le Saëc P; Mauxion T; Faivre-Chauvet A; Davodeau F; Goldenberg DM; Bardiès M; Barbet J
    Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2153-64. PubMed ID: 21858527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Lee D; Li M; Bednarz B; Schultz MK
    Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biokinetic Modeling and Dosimetry for Optimizing Intraperitoneal Radioimmunotherapy of Ovarian Cancer Microtumors.
    Palm S; Bäck T; Haraldsson B; Jacobsson L; Lindegren S; Albertsson P
    J Nucl Med; 2016 Apr; 57(4):594-600. PubMed ID: 26769860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy with α-particle-emitting radionuclides.
    Seidl C
    Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.
    Iznaga-Escobar N; Torres LA; Morales A; Ramos M; Alvarez I; Pérez N; Fraxedas R; Rodríguez O; Rodríguez N; Pérez R; Lage A; Stabin MG
    J Nucl Med; 1998 Jan; 39(1):15-23. PubMed ID: 9443731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides.
    Woodward J; Kennel SJ; Stuckey A; Osborne D; Wall J; Rondinone AJ; Standaert RF; Mirzadeh S
    Bioconjug Chem; 2011 Apr; 22(4):766-76. PubMed ID: 21434681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered liposomes for potential alpha-particle therapy of metastatic cancer.
    Sofou S; Thomas JL; Lin HY; McDevitt MR; Scheinberg DA; Sgouros G
    J Nucl Med; 2004 Feb; 45(2):253-60. PubMed ID: 14960644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia.
    Sgouros G; Ballangrud AM; Jurcic JG; McDevitt MR; Humm JL; Erdi YE; Mehta BM; Finn RD; Larson SM; Scheinberg DA
    J Nucl Med; 1999 Nov; 40(11):1935-46. PubMed ID: 10565792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 225Ac for vascular targeted radioimmunotherapy of lung tumors.
    Kennel SJ; Chappell LL; Dadachova K; Brechbiel MW; Lankford TK; Davis IA; Stabin M; Mirzadeh S
    Cancer Biother Radiopharm; 2000 Jun; 15(3):235-44. PubMed ID: 10941530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation and the advantage of longer-lived radionuclides in radioimmunotherapy.
    Howell RW; Goddu SM; Rao DV
    Med Phys; 1998 Jan; 25(1):37-42. PubMed ID: 9472824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the effect of daughter migration on dosimetry estimates for unlabeled actinium-225.
    Tronchin S; Forster J; Hickson K; Bezak E
    Med Phys; 2024 Jul; 51(7):5032-5044. PubMed ID: 38197481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.